Trial Profile
Treatment of hepatocellular carcinoma on child cirrhosis A/B7 by intra-arterial injection of a Lipiodol and Idarubicin emulsion : a multicentric single-arm phase II study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2024
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary) ; Idarubicin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms LIDA-BII
- 15 Jan 2024 Planned End Date changed from 1 May 2024 to 18 Jan 2026.
- 15 Jan 2024 Planned primary completion date changed from 1 Aug 2023 to 18 Dec 2024.
- 07 Jan 2020 Planned End Date changed from 1 Jun 2021 to 1 May 2024.